DeFloria announced Thursday that its experimental cannabis-based drug for autism spectrum disorder showed positive early results, with patients tolerating the treatment well across multiple dose levels. The drug, AJA001, being developed as a multi-compound hemp extract with a full spectrum of cannabinoids, demonstrated safety at daily doses up to 660 …
This story was republished with permission from Crain’s Cleveland. Statewide cannabis sales have held relatively steady at elevated levels in the four months since the launch of Ohio’s adult-use market, according to the latest figures from the Ohio Division of Cannabis Control. Ohio dispensaries sold a little shy of $74… …
For an industry that once treated every dispensary visit like a special occasion, cannabis retail is starting to look remarkably ordinary. A new analysis of more than 61 million transactions from 1,700 dispensaries shows consumers treating cannabis shopping more like typical retail, complete with weekend rushes, brand loyalty and a …
The parent company of online cannabis advertising giant Weedmaps – California-based WM Technology Inc. (Nasdaq: MAPS) – plans to raise $224.3 million by more than doubling the number of shares issued to date to stockholders, the company said in a pair of prospectus filings with securities regulators this month. The …